Most Recent
As it readies its civil penalty suit against tech company Nuix for trial, ASIC has flagged a possible dispute about the extent of penalty privilege pleaded by a handful of former and current directors named in the case.
A shareholder class action against software company Nuix will go ahead as planned, after a stay application threatened to put the proceeding on ice pending the outcome of a separate case brought by ASIC.
Twenty barristers have risen to the ranks of senior counsel in New South Wales, including a veteran defamation barrister, two counsel with class action expertise and part of the team that saw ASIC's claims against two Rio Tinto executives dropped.
Max Twigg, race car driver and former owner of the famous Byron Bay Hotel, has lost an appeal of a judge’s finding that he misappropriated around $100 million in family trust money and took steps to conceal the transfer of funds from his mother.
The Commonwealth is currently facing 83 negligence lawsuits in the Federal Court by asylum seekers who claim the government knew they were vulnerable to physical and psychological injuries and other illnesses, which could be exacerbated by detention in prison-like facilities.
A Federal Court judge has criticised the liquidators of coal mining company Delta for waiting over two years to file insolvent trading proceedings against former directors when the same issues of solvency had already been raised in two other cases.
A court has dismissed a claim by the Australian Government for $325 million against pharmaceutical companies Sanofi and Bristol-Myers Squibb allegedly owed for excess subsidies it paid for blood-thinner Plavix as a result of an interlocutory injunction blocking a generic version of the blockbuster drug.
The Commonwealth of Australia is weighing a bid to strike out Otsuka Pharmaceutical's defence as the government seeks lost subsidies after an almost seven-year long patent dispute over the antipsychotic drug, Abilify.